Canada Enteral Nutrition Market Demand and Forecast | 2031

The Canada enteral nutrition market size is expected to grow from CA$ 514.33 million in 2023 to CA$ 817.11 million by 2031; the market is estimated to register a CAGR of 6.0% from 2023 to 2031.

Enteral nutrition refers to any method of feeding that involves the gastrointestinal (GI) tract to deliver nutrition for fulfilling an individual’s caloric requirements. It can include a normal oral diet, liquid supplements, or delivery using a tube (tube feeding). Enteral nutrition is necessary for patients whose energy and nutritional needs cannot be met by a regular food intake. The Canada enteral nutrition market report emphasizes the key factors driving the market and depicts the developments of prominent players.

Key factors bolstering the Canada enteral nutrition market include a surge in the prevalence of cachexia and related disorders and a rise in the prevalence of gastrointestinal diseases. Further, the specific formulations and plant-based nutrition products are expected to bring new Canada enteral nutrition market trends in the coming years.

Growth Drivers and Restraints:

The Canadian Mental Health Association celebrates Eating Disorder Awareness Week by wearing purple on February 1, Every year. Cachexia, anorexia, and eating disorders are related in a way that highlights the complex interactions between physiological, psychological, and metabolic aspects. Cachexia is a multifunctional disease that causes extreme weight loss, skeletal muscle and adipose tissue loss, metabolic regulation imbalance, and food intake reduction. In people with underlying medical disorders, anorexia (a chronic lack of appetite or reduced food intake) may play a role in the onset or aggravation of cachexia. Reduced calorie intake in anorexic patients further hampers their metabolic capacity to preserve muscle mass, store vital nutrients, and attain general metabolic equilibrium, subsequently accelerating the development of cachexia. According to the National Initiative for Eating Disorders, as of 2023, anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), avoidance restrictive food intake disorder (ARFID), and otherwise specified feeding and eating disorder (OSFED) affect approximately 1 million Canadians who have been diagnosed with an eating disorder. Additionally, according to the Canadian Community Health Survey, 1.8% of women aged 65 or more and 2.6% of women from the age group of 50–64 reported having an eating disorder. Thus, with the burgeoning incidence of cachexia, anorexia, and eating disorders—collaborative efforts, awareness initiatives, and implementation of tailored interventions that target both the physical and psychological aspects of the abovementioned conditions support the Canada enteral nutrition market growth.

For many years, the enteral nutrition method has been in use to feed patients who are unable or unwilling to consume food in quantities sufficient for their daily needs. However, the method may lead to various complications due to the techniques applied. When a wide bore tube is used for feeding, the size and rigidity of the tube tend to produce inflammation and irritation. The tube can also encourage gastroesophageal reflux. Fine-bore tubes are prone to coil up in the oropharynx region or to wander off course into the trachea during the insertion process, particularly since the patients are unconscious during the insertion process. Owing to the risk of misplacement, it is important to ensure the correct positioning of a tube before feeding, as it may adversely affect the aspiration in the stomach if not placed properly. These are the mechanical or tube-related aspects that limit the adoption of enteral nutrition methods.

Further, enteral feeding may be followed by nausea, vomiting, diarrhea, constipation, and many gastrointestinal complications. According to Clinical Nutrition Espen, 20% of the total patients on enteral nutrition suffer from nausea, vomiting, bloating, and abdominal cramps. Diarrhea is the most common gastrointestinal complication caused by enteral nutrition, occurring within a wide range of 2–63%. Dehydration, hyperglycemia, electrolyte abnormalities, vitamin and trace element deficiencies, liver function abnormalities, and other metabolic abnormalities may arise during enteral feeding due to the imprudent choice of feed and lack of adequate monitoring. Thus, mechanical complications, gastrointestinal complications, metabolic complications, etc., hinder the Canada enteral nutrition market growth.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Canada Enteral Nutrition Market: Strategic Insights

Canada Enteral Nutrition Market

• Market Size 2023
  CA$ 514.33 Million
• Market Size 2031
  CA$ 817.11 Million

Market Dynamics

GROWTH DRIVERS

• Surge in Prevalence of Cachexia and Related Disorders
• Rise in Prevalence of Gastrointestinal Diseases

FUTURE TRENDS

• Specific Formulations and Plant-Based Nutrition Products

OPPORTUNITIES

• Use of Next-Generation Technologies to Ensure Proper Feeding Routines

Regional Overview

• Canada

Market Segmentation

Disease Indication

• Orthopedic Disorders
• cardiovascular Disorders
• Oncology
• Neurological Disorders

Formula Type

• Standard Formulas
• Peptide Formulas
• Specialized Formulas

Route Of Administration

• Oral
• Tube Feed

End User

• Long Term Care Facilities
• Hospitals

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Report Segmentation and Scope:

The Canada enteral nutrition market analysis has been carried out by considering the following segments: disease indication, formula type, route of administration, and end user. Based on disease indication, the market is differentiated into Orthopedic Disorders, Cardiovascular Disorders, Oncology, Neurological Disorders, and Others. By route of administration, the Canada enteral nutrition market is segmented into oral and tube feed. In terms of formula type, the market is differentiated into standard formulas (whole protein formulas), peptide formulas (semi-elemental formulas), and specialized formulas. On the basis of end users, the Canada enteral nutrition market is classified into hospitals, long-term care facilities, and others.

Segmental Analysis:

Based on disease indication, the orthopedic disorders segment held the largest Canada enteral nutrition market share in 2023. The cardiovascular disorders segment is anticipated to register the highest CAGR during 2023–2031.

Canada Enteral Nutrition Market, by Disease Indication – 2023 and 2031

Access Data

Based on formula type, the companion animals segment held a larger market share in 2023. The standard formulas segment held the largest Canada enteral nutrition market share; it is anticipated to register the highest CAGR from 2023 to 2031. Based on the route of administration, the oral segment held a larger share of the Canada enteral nutrition market in 2023, and the same segment is anticipated to register a higher CAGR during 2023–2031. In terms of end user, the long-term care facilities segment is anticipated to account for a significant market share during 2023–2031.

Country Overview:

The Canadian Cancer Statistics Advisory Committee estimated ~225,800 new cancer cases and 83,300 deaths due to cancer in Canada in 2020. According to Canadian Cancer Society estimates, 2 in 5 Canadians are diagnosed with cancer in their lifetime. Per the same source, ~229,200 people in the country were diagnosed with cancer and 84,600 died from it in 2021. The Canadian Digestive Health Foundation states that millions of Canadians live with digestive disease. ~20 million Canadians, i.e., 2 of every 3 people, suffer from digestive disorders yearly. Parenteral and enteral nutrition helps administer vital nutrients, which helps maintain strength, energy, and hydration levels in patients suffering from cancer (all stages). The increasing prevalence of chronic conditions, such as cancer and gastrointestinal disorders, propel the demand for enteral and parenteral nutrition products in Canada. Enteral nutrition is also a preferred method of nutritional support when the gastrointestinal tract is functional, but the patient is unable to have an adequate oral intake of nutrients to fulfill nutritional requirements.

The Canadian government and private organizations are taking several initiatives to boost the enteral nutrition practice. For instance, the Canadian Cancer Society is creating awareness about enteral nutrition and tube feeding among cancer patients. Further, the BC Home Enteral Nutrition (HEN) Program, in collaboration with Oley Foundation, supports patients with specialized nutrition needs from British Columbia and the Yukon. It creates awareness and helps patients live enhanced life through advocacy, education, and networking. The Canada enteral nutrition market forecast can help stakeholders in this marketplace plan their growth strategies.

Competitive Landscape and Key Companies:

Nestle SA, Abbott Laboratories, Fresenius Medical Care AG & Co KgaA, Koninklijke DSM NV, and B Barun SE are among the prominent players profiled in the Canada enteral nutrition market report. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the burgeoning consumer demand and expand their product range in specialty portfolios.

Canada Enteral Nutrition Report Scope